Total Payments
$5,310
2024 Payments
$910.06
Companies
43
Transactions
333
Medicare Patients
2,050
Medicare Billing
$217,103
Payment Breakdown by Category
Food & Beverage$4,840 (91.2%)
Education$261.83 (4.9%)
Other$208.00 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,840 | 327 | 91.2% |
| Education | $261.83 | 4 | 4.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208.00 | 2 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $1,369 | 96 | $0 (2024) |
| ViiV Healthcare Company | $731.24 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $384.91 | 25 | $0 (2024) |
| Janssen Products, LP | $254.98 | 3 | $0 (2021) |
| Amgen Inc. | $244.22 | 17 | $0 (2024) |
| Janssen Biotech, Inc. | $221.76 | 20 | $0 (2023) |
| GlaxoSmithKline, LLC. | $220.41 | 14 | $0 (2024) |
| Becton, Dickinson and Company | $208.00 | 2 | $0 (2024) |
| EMD Serono, Inc. | $153.56 | 11 | $0 (2024) |
| Theratechnologies Inc. | $139.71 | 10 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $910.06 | 52 | Gilead Sciences, Inc. ($374.86) |
| 2023 | $822.06 | 50 | Gilead Sciences, Inc. ($320.19) |
| 2022 | $860.00 | 49 | Gilead Sciences, Inc. ($272.17) |
| 2021 | $837.62 | 59 | Gilead Sciences, Inc. ($250.69) |
| 2020 | $269.66 | 20 | ViiV Healthcare Company ($44.29) |
| 2019 | $443.25 | 31 | Gilead Sciences, Inc. ($71.34) |
| 2018 | $487.62 | 31 | AstraZeneca Pharmaceuticals LP ($83.26) |
| 2017 | $679.84 | 41 | AstraZeneca Pharmaceuticals LP ($149.36) |
All Payment Transactions
333 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: HIV | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.82 | General |
| 11/29/2024 | Becton, Dickinson and Company | Site-Rite (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $53.00 | General |
| Category: Catheter Care and Medication Delivery | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.05 | General |
| 10/25/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/23/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: HIV | ||||||
| 10/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.65 | General |
| 10/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.60 | General |
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $15.46 | General |
| Category: Infectious Disease | ||||||
| 08/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.32 | General |
| 08/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.30 | General |
| 07/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.75 | General |
| 07/12/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: HIV | ||||||
| 06/27/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Bone Health | ||||||
| 06/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $3.52 | General |
| 06/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.11 | General |
| 06/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.98 | General |
| 06/18/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: GI | ||||||
| 06/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.35 | General |
| 06/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.30 | General |
| 06/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 470 | 961 | $90,630 | $54,198 |
| 2022 | 10 | 571 | 1,081 | $99,180 | $60,454 |
| 2021 | 10 | 532 | 923 | $87,985 | $52,657 |
| 2020 | 10 | 477 | 899 | $85,120 | $49,794 |
Total Patients
2,050
Total Services
3,864
Medicare Billing
$217,103
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 300 | $45,000 | $30,204 | 67.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 195 | $24,375 | $12,902 | 52.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $7,800 | $5,546 | 71.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $2,940 | $1,746 | 59.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 38 | 124 | $4,340 | $1,359 | 31.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 69 | 85 | $3,140 | $829.56 | 26.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 24 | $840.00 | $815.28 | 97.1% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 24 | 25 | $755.00 | $510.72 | 67.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $330.00 | $178.20 | 54.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 27 | 78 | $780.00 | $81.10 | 10.4% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 15 | 66 | $330.00 | $26.85 | 8.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 326 | $40,750 | $22,890 | 56.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 220 | $33,000 | $22,584 | 68.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 52 | 52 | $10,400 | $7,620 | 73.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $3,290 | $2,335 | 71.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 46 | 46 | $1,610 | $1,550 | 96.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 46 | 129 | $4,515 | $1,543 | 34.2% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 46 | 46 | $1,380 | $923.06 | 66.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 75 | 87 | $3,045 | $878.45 | 28.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 27 | 79 | $790.00 | $97.14 | 12.3% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 24 | 80 | $400.00 | $32.68 | 8.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 130 | 336 | $41,760 | $25,256 | 60.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 100 | 157 | $23,235 | $15,520 | 66.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 34 | 34 | $6,500 | $5,069 | 78.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 35 | 35 | $7,335 | $3,449 | 47.0% |
About Dr. Rodolfo Munera, MD
Dr. Rodolfo Munera, MD is a Infectious Disease healthcare provider based in Clifton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154382760.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rodolfo Munera, MD has received a total of $5,310 in payments from pharmaceutical and medical device companies, with $910.06 received in 2024. These payments were reported across 333 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($4,840).
As a Medicare-enrolled provider, Munera has provided services to 2,050 Medicare beneficiaries, totaling 3,864 services with total Medicare billing of $217,103. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Clifton, NJ
- Active Since 03/31/2006
- Last Updated 10/31/2011
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154382760
Products in Payments
- FARXIGA (Drug) $262.95
- DOVATO (Drug) $230.05
- PREZCOBIX (Drug) $222.34
- SYMTUZA (Drug) $209.96
- CABENUVA (Biological) $185.11
- FACS (Device) $155.00
- TRELEGY ELLIPTA (Drug) $139.45
- EVENITY (Biological) $126.54
- EGRIFTA (Drug) $126.45
- Vascepa (Drug) $123.85
- Cologuard Collection Kit (Device) $107.37
- TRIUMEQ (Drug) $102.06
- APRETUDE (Biological) $100.28
- JULUCA (Drug) $98.77
- JANUVIA (Drug) $91.42
- INTELLIS ADAPTIVESTIM (Device) $88.96
- Dexcom G6 Transmitter (Medical Supply) $88.39
- AIRSUPRA (Drug) $77.29
- Mytesi (Drug) $68.10
- Biktarvy (Drug) $60.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Clifton
Dr. Sessine Najjar, M.d, M.D
Infectious Disease — Payments: $15,083
Infectious Disease $15,083
Dr. Frederick Okoye, Md, MD
Infectious Disease — Payments: $2,346
Infectious Disease $2,346
Dr. Jakaulla Khan, Md, MD
Infectious Disease — Payments: $1,301
Infectious Disease $1,301
Gabriel Karkenny
Infectious Disease — Payments: $694.81
Infectious Disease $694.81
Sabah Varoqua, M.d, M.D
Infectious Disease — Payments: $237.16
Infectious Disease $237.16
Dr. Yasmeen Sultana, Md, MD
Infectious Disease — Payments: $17.91
Infectious Disease $17.91